1-2 of 2
Liv Meert, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clofarabine in Combination with a Standard Remission Induction Regimen in Patients 18-60 Years Old with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Combined Phase I/II Results of the EORTC/Gimema AML-14A Trial

Dominik L.D. Selleslag, MD, Stefan Suciu, Giovanna Meloni, MD, Petra Muus, MD PhD, Constantijn J.M. Halkes, MD PhD, Adriano Venditti, MD, Safaa M Ramadan, MD PhD, Hans Pruijt, MD PhD, Liv Meert, MSc, Marco Vignetti, MD, Jean-Pierre Marie, MD, Dominique Bron, MD PhD, Theo de Witte, MD, Sergio Amadori, MD, Roelof Willemze, MD PhD, Frederic Baron, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3675.
https://doi.org/10.1182/blood.V124.21.3675.3675
Published: 2014
Journal Articles

Improved Overall Survival with Gemtuzumab Ozogamicin (GO) Compared with Best Supportive Care (BSC) in Elderly Patients with Untreated Acute Myeloid Leukemia (AML) Not Considered Fit for Intensive Chemotherapy: Final Results from the Randomized Phase III Study (AML-19) of the EORTC and Gimema Leukemia Groups

Sergio Amadori, MD, Stefan Suciu, PhD, Dominik Selleslag, MD, Elena Rossetti, MD, Gianluca Gaidano, MD PhD, Maurizio Musso, MD, Luciana Annino, MD, Adriano Venditti, Domenico Magro, MD, Paolo de Fabritiis, MD, Petra Muus, MD, Giuliana Alimena, MD, Marco Mancini, Anne Hagemeijer, MD, Francesca Cotugno, Marco Vignetti, MD, Paola Fazi, MD, Liv Meert, MSc, Safaa M Ramadan, MD PhD, Roelof Willemze, MD PhD, Theo de Witte, MD, Frederic Baron
Journal: Blood
Blood (2014) 124 (21): 619.
https://doi.org/10.1182/blood.V124.21.619.619
Published: 2014